117 related articles for article (PubMed ID: 9336237)
1. Localization of perlecan (or a perlecan-related macromolecule) to isolated microglia in vitro and to microglia/macrophages following infusion of beta-amyloid protein into rodent hippocampus.
Miller JD; Cummings J; Maresh GA; Walker DG; Castillo GM; Ngo C; Kimata K; Kinsella MG; Wight TN; Snow AD
Glia; 1997 Oct; 21(2):228-43. PubMed ID: 9336237
[TBL] [Abstract][Full Text] [Related]
2. Novel purification and detailed characterization of perlecan isolated from the Engelbreth-Holm-Swarm tumor for use in an animal model of fibrillar A beta amyloid persistence in brain.
Castillo GM; Cummings JA; Ngo C; Yang W; Snow AD
J Biochem; 1996 Aug; 120(2):433-44. PubMed ID: 8889831
[TBL] [Abstract][Full Text] [Related]
3. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
Sekiguchi RT; Potter-Perigo S; Braun K; Miller J; Ngo C; Fukuchi K; Wight TN; Kimata K; Snow AD
J Neurosci Res; 1994 Aug; 38(6):670-86. PubMed ID: 7807583
[TBL] [Abstract][Full Text] [Related]
4. Detection and quantitation of perlecan mRNA levels in Alzheimer's disease and normal aged hippocampus by competitive reverse transcription-polymerase chain reaction.
Maresh GA; Erezyilmaz D; Murry CE; Nochlin D; Snow AD
J Neurochem; 1996 Sep; 67(3):1132-44. PubMed ID: 8752120
[TBL] [Abstract][Full Text] [Related]
5. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
[TBL] [Abstract][Full Text] [Related]
7. A beta and perlecan in rat brain: glial activation, gradual clearance and limited neurotoxicity.
Holcomb LA; Gordon MN; Benkovic SA; Morgan DG
Mech Ageing Dev; 2000 Jan; 112(2):135-52. PubMed ID: 10690926
[TBL] [Abstract][Full Text] [Related]
8. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain.
Snow AD; Sekiguchi R; Nochlin D; Fraser P; Kimata K; Mizutani A; Arai M; Schreier WA; Morgan DG
Neuron; 1994 Jan; 12(1):219-34. PubMed ID: 8292358
[TBL] [Abstract][Full Text] [Related]
9. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
Castillo GM; Cummings JA; Yang W; Judge ME; Sheardown MJ; Rimvall K; Hansen JB; Snow AD
Diabetes; 1998 Apr; 47(4):612-20. PubMed ID: 9568695
[TBL] [Abstract][Full Text] [Related]
10. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
Castillo GM; Ngo C; Cummings J; Wight TN; Snow AD
J Neurochem; 1997 Dec; 69(6):2452-65. PubMed ID: 9375678
[TBL] [Abstract][Full Text] [Related]
11. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.
Dodge GR; Boesler EW; Jimenez SA
Lab Invest; 1995 Nov; 73(5):649-57. PubMed ID: 7474938
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the heparan sulfate proteoglycan, perlecan, by injury and interleukin-1alpha.
García de Yébenes E; Ho A; Damani T; Fillit H; Blum M
J Neurochem; 1999 Aug; 73(2):812-20. PubMed ID: 10428080
[TBL] [Abstract][Full Text] [Related]
13. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization.
Murdoch AD; Liu B; Schwarting R; Tuan RS; Iozzo RV
J Histochem Cytochem; 1994 Feb; 42(2):239-49. PubMed ID: 7507142
[TBL] [Abstract][Full Text] [Related]
14. Distribution of perlecan in mouse hippocampus following intracerebroventricular kainate injections.
Shee WL; Ong WY; Lim TM
Brain Res; 1998 Jul; 799(2):292-300. PubMed ID: 9675317
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of abdominal aortic aneurysms: possible role of differential production of proteoglycans by smooth muscle cells.
Melrose J; Whitelock J; Xu Q; Ghosh P
J Vasc Surg; 1998 Oct; 28(4):676-86. PubMed ID: 9786264
[TBL] [Abstract][Full Text] [Related]
16. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.
Whitelock JM; Murdoch AD; Iozzo RV; Underwood PA
J Biol Chem; 1996 Apr; 271(17):10079-86. PubMed ID: 8626565
[TBL] [Abstract][Full Text] [Related]
17. Basement membrane proteoglycans are of epithelial origin in rodent skin.
Yamane Y; Yaoita H; Couchman JR
J Invest Dermatol; 1996 Mar; 106(3):531-7. PubMed ID: 8648189
[TBL] [Abstract][Full Text] [Related]
18. A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant.
Joseph SJ; Ford MD; Barth C; Portbury S; Bartlett PF; Nurcombe V; Greferath U
Development; 1996 Nov; 122(11):3443-52. PubMed ID: 8951060
[TBL] [Abstract][Full Text] [Related]
19. Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro.
van Det NF; van den Born J; Tamsma JT; Verhagen NA; van den Heuvel LP; Berden JH; Bruijn JA; Daha MR; van der Woude FJ
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):759-68. PubMed ID: 7537959
[TBL] [Abstract][Full Text] [Related]
20. Perlecan is a component of cartilage matrix and promotes chondrocyte attachment.
SundarRaj N; Fite D; Ledbetter S; Chakravarti S; Hassell JR
J Cell Sci; 1995 Jul; 108 ( Pt 7)():2663-72. PubMed ID: 7593307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
